Fosinopril

The dosage of Fosinopril is highly individualized based on the patient's clinical response, the condition being treated, and the presence of other medical issues.

Hypertension

For most adult patients with high blood pressure, the recommended starting dose is 10 mg taken once daily. Depending on the blood pressure response, your healthcare provider may increase the dose. The usual maintenance range is 20 mg to 40 mg per day, administered as a single dose. While some patients may require 80 mg daily, doses above 80 mg have not been extensively studied and are generally not recommended. If blood pressure is not controlled with Fosinopril alone, a diuretic (water pill) may be added.

Heart Failure

The starting dose for heart failure is typically lower to avoid a sudden drop in blood pressure. The recommended initial dose is 10 mg once daily. Your doctor will closely monitor you for 'first-dose hypotension' (a sharp drop in blood pressure after the first dose). If the initial dose is well-tolerated, the dosage may be increased over several weeks. The target dose for heart failure is usually 40 mg once daily. If you have been taking high doses of diuretics or are dehydrated, your doctor may start you on a 5 mg dose.

Fosinopril is approved for the treatment of hypertension in children who weigh more than 50 kg (approximately 110 lbs). The standard starting dose for these children is 10 mg once daily. For children weighing between 20 kg and 50 kg, the dose must be carefully calculated by a pediatric specialist, often starting at lower increments. Fosinopril is generally not recommended for children weighing less than 20 kg or for infants, as its safety and effectiveness in very young pediatric populations have not been established.

Renal Impairment

One of the unique benefits of Fosinopril is its dual elimination route. In patients with impaired kidney function (reduced creatinine clearance), the liver compensates by increasing its excretion of the drug. Consequently, for most patients with renal impairment, no initial dosage adjustment is necessary. However, your doctor will still monitor your kidney function and potassium levels closely.

Hepatic Impairment

Similar to renal impairment, the kidneys can compensate for reduced liver function. Generally, no initial dosage adjustment is required for patients with stable hepatic cirrhosis. However, because the conversion of Fosinopril to its active form (fosinoprilat) occurs in the liver, the rate of activation may be slower in these patients.

Elderly Patients

Clinical studies have shown no overall differences in the safety or effectiveness of Fosinopril between elderly patients (65 years and older) and younger patients. However, because older adults are more likely to have decreased kidney or liver function and may be taking multiple medications, healthcare providers usually start at the lower end of the dosing range.

• Consistency: Take Fosinopril at the same time every day to maintain a steady level of the medication in your bloodstream.
• With or Without Food: Fosinopril can be taken with or without food. If it causes stomach upset, taking it with a meal may help.
• Swallow Whole: Tablets should be swallowed whole with a glass of water. Do not crush or chew the tablets unless specifically instructed by your pharmacist.
• Storage: Store the medication at room temperature (20°C to 25°C or 68°F to 77°F), away from moisture, heat, and direct light. Keep the container tightly closed.

If you miss a dose of Fosinopril, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular schedule. Do not take two doses at once to make up for a missed one, as this increases the risk of severe low blood pressure.

The most likely symptom of a Fosinopril overdose is excessive hypotension (very low blood pressure), which can cause severe dizziness, fainting, or lightheadedness. Other signs may include electrolyte imbalances (such as high potassium) or kidney failure. In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Treatment usually involves intravenous fluids to support blood pressure.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking this medication without medical guidance, as stopping suddenly can cause your blood pressure to rise rapidly.

While Fosinopril is generally well-tolerated, some patients may experience common side effects. These are typically mild and may disappear as your body adjusts to the medication.

• Dry Cough: This is the most characteristic side effect of ACE inhibitors. It is typically a persistent, non-productive (no phlegm) tickle in the throat. It occurs because the drug prevents the breakdown of bradykinin in the lungs. If the cough becomes bothersome, talk to your doctor; it usually resolves within 1 to 4 weeks after stopping the drug.
• Dizziness or Lightheadedness: This often occurs during the first few days of treatment or when the dose is increased, as your body adapts to lower blood pressure. It is most common when rising quickly from a sitting or lying position.
• Headache: Mild to moderate headaches may occur early in treatment.
• Fatigue: Some patients report feeling unusually tired or weak.

• Nausea and Vomiting: Some gastrointestinal distress may occur.
• Diarrhea: Changes in bowel habits are possible but usually temporary.
• Sexual Dysfunction: Some men may experience erectile dysfunction, though this is less common than with beta-blockers or diuretics.
• Muscle Cramps: These may be related to changes in electrolyte levels.
• Rash: A mild skin rash or itching (pruritus) may develop.

• Hyperkalemia: Fosinopril can cause the body to retain potassium. While often asymptomatic, very high potassium levels can lead to dangerous heart rhythm disturbances.
• Neutropenia/Agranulocytosis: A rare but serious decrease in white blood cells, which can make you more susceptible to infections.
• Psoriasis Exacerbation: In rare cases, ACE inhibitors may worsen skin conditions like psoriasis.
• Dysgeusia: A temporary change or loss of the sense of taste.

> Warning: Stop taking Fosinopril and call your doctor or emergency services immediately if you experience any of the following:

1. 1Angioedema: This is a life-threatening allergic reaction involving swelling of the face, lips, tongue, or throat. It can block your airway. This reaction is more common in Black patients than in non-Black patients.
2. 2Severe Hypotension (Fainting): If you feel like you might pass out, your blood pressure may be too low.
3. 3Kidney Dysfunction: Symptoms include a significant decrease in urine output, swelling in the feet or ankles, or sudden weight gain.
4. 4Liver Problems (Hepatotoxicity): Signs include yellowing of the skin or eyes (jaundice), dark urine, severe stomach pain, or persistent nausea.
5. 5High Potassium Symptoms: Muscle weakness, a slow or irregular heartbeat, and a tingly feeling.

With prolonged use, the most significant concern is the impact on renal (kidney) function. In some patients, especially those with pre-existing kidney disease or severe heart failure, long-term use of Fosinopril can lead to a gradual decline in kidney function. Regular blood tests are required to monitor this. Additionally, chronic cough can persist as long as the medication is taken. There is no evidence that Fosinopril causes cumulative toxicity or long-term organ damage when monitored correctly by a healthcare professional.

Fetal Toxicity: Fosinopril carries a strict FDA Black Box Warning regarding its use during pregnancy. When used in pregnancy during the second and third trimesters, ACE inhibitors can cause injury and even death to the developing fetus. Risks include skull hypoplasia (underdeveloped skull), anuria (failure of kidneys to produce urine), hypotension, and renal failure in the newborn. If pregnancy is detected, Fosinopril must be discontinued as soon as possible. Discuss alternative blood pressure management options with your doctor if you are planning to become pregnant.

Report any unusual symptoms or side effects to your healthcare provider promptly. They can help determine if the symptom is related to Fosinopril or another underlying condition.

Fosinopril is a powerful cardiovascular medication that requires careful monitoring. Patients must be aware that the first few doses may cause a significant drop in blood pressure, especially if they are also taking diuretics or are dehydrated. It is essential to stay hydrated and follow all laboratory monitoring schedules set by your healthcare provider. You should not start or stop any other medications, including over-the-counter drugs and supplements, without consulting your doctor, as many substances can interact with Fosinopril's effects on blood pressure and potassium levels.

Full Text Summary: Fosinopril, like all ACE inhibitors, can cause serious injury or death to an unborn baby if taken during pregnancy. Use of drugs that act directly on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death. Resulting oligohydramnios (low amniotic fluid) can be associated with fetal lung hypoplasia and skeletal deformations. Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death. When pregnancy is detected, discontinue Fosinopril as soon as possible.

• Angioedema Risk: There is a risk of sudden swelling of the face, extremities, eyes, lips, and tongue (angioedema). This can occur at any time during treatment. If it involves the upper airway, it can be fatal. Patients with a history of angioedema (even if not caused by an ACE inhibitor) are at higher risk.
• Anaphylactoid Reactions during Desensitization: Patients taking ACE inhibitors while undergoing desensitization treatment (e.g., for bee sting allergies) have experienced life-threatening allergic reactions.
• Hypotension (Low Blood Pressure): Excessive hypotension is rare in uncomplicated hypertensive patients but can occur in patients who are salt/volume depleted due to prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting.
• Hepatic Failure: Rarely, ACE inhibitors have been associated with a syndrome that starts with cholestatic jaundice and progresses to fulminant hepatic necrosis and sometimes death. If you develop jaundice or marked elevations of liver enzymes, the drug must be stopped.
• Impaired Renal Function: In patients with severe heart failure, treatment with Fosinopril may lead to oliguria (low urine output) or progressive azotemia (high nitrogen levels in the blood).

Your healthcare provider will require regular blood tests to ensure Fosinopril is working safely. These include:

• Serum Creatinine/BUN: To monitor kidney function.
• Potassium Levels: To check for hyperkalemia (high potassium).
• Complete Blood Count (CBC): Occasionally checked to monitor white blood cell counts, especially in patients with autoimmune conditions like lupus.
• Blood Pressure Monitoring: Both at the clinic and potentially at home to ensure the dose is effective.

Fosinopril can cause dizziness, lightheadedness, or fainting, especially during the first few days of treatment or after a dose increase. Do not drive, operate heavy machinery, or participate in hazardous activities until you know how this medication affects you. If you feel dizzy, sit or lie down immediately.

Alcohol can enhance the blood-pressure-lowering effect of Fosinopril, which may lead to severe dizziness or fainting. It is generally advised to limit or avoid alcohol consumption while taking this medication, particularly when starting therapy.

Do not stop taking Fosinopril abruptly. While it does not typically cause a 'withdrawal syndrome' like beta-blockers, stopping suddenly will cause your blood pressure to return to pre-treatment levels, increasing the risk of cardiovascular events. If the medication needs to be stopped, your doctor will provide a plan to transition you to a different therapy.

> Important: Discuss all your medical conditions, including any history of kidney disease, liver disease, or severe allergies, with your healthcare provider before starting Fosinopril.

• Aliskiren: In patients with diabetes or renal impairment (GFR < 60 mL/min), the use of Fosinopril with aliskiren (a direct renin inhibitor) is strictly contraindicated. This combination significantly increases the risk of kidney failure, high potassium, and dangerously low blood pressure.
• Sacubitril/Valsartan (Entresto): Fosinopril must not be taken within 36 hours of taking a neprilysin inhibitor like sacubitril. This combination significantly increases the risk of life-threatening angioedema (swelling).

• Potassium-Sparing Diuretics: Medications such as spironolactone, triamterene, or amiloride can cause potassium levels to skyrocket when taken with Fosinopril. This can lead to fatal heart arrhythmias.
• Lithium: Fosinopril can reduce the clearance of lithium by the kidneys, leading to toxic levels of lithium in the blood. Symptoms of lithium toxicity include tremors, confusion, and seizures.
• Injectable Gold (Sodium Aurothiomalate): Nitritoid reactions (symptoms including facial flushing, nausea, vomiting, and hypotension) have been reported rarely in patients on therapy with injectable gold and concomitant ACE inhibitor therapy.

• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Drugs like ibuprofen (Advil, Motrin), naproxen (Aleve), and celecoxib (Celebrex) can reduce the blood-pressure-lowering effect of Fosinopril. Furthermore, in patients who are elderly or have poor kidney function, the combination can lead to acute kidney failure.
• Other Antihypertensives: Taking Fosinopril with other blood pressure meds (like beta-blockers or calcium channel blockers) has an additive effect. While often intended, it requires careful monitoring to prevent excessively low blood pressure.
• Insulin and Oral Antidiabetics: ACE inhibitors may increase sensitivity to insulin, potentially leading to hypoglycemia (low blood sugar). Diabetic patients should monitor their blood sugar closely when starting Fosinopril.

• Salt Substitutes: Many salt substitutes contain potassium chloride instead of sodium chloride. Using these while taking Fosinopril can lead to dangerously high potassium levels (hyperkalemia).
• High-Potassium Foods: While a healthy diet is encouraged, excessive consumption of very high-potassium foods (like bananas, oranges, and leafy greens) should be discussed with your doctor.
• Alcohol: As mentioned, alcohol can worsen the dizzying effects of Fosinopril by further lowering blood pressure.

• Potassium Supplements: These should be avoided unless specifically prescribed by your doctor while on Fosinopril.
• Natural Licorice: Can cause sodium retention and potassium loss, interfering with the drug's effectiveness.
• St. John's Wort: While not a direct metabolic interaction, it can affect blood pressure management in some patients.

Fosinopril may cause false-negative results in certain lab tests. It can also interfere with serum digoxin assays using certain methods. Always inform laboratory staff and your doctors that you are taking an ACE inhibitor.

For each interaction, the primary management strategy is frequent monitoring of blood pressure, kidney function, and electrolyte levels. Your doctor may need to adjust the dose of one or both medications.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including those purchased without a prescription.

There are several situations where Fosinopril must NEVER be used because the risks far outweigh any potential benefits:

1. 1History of Angioedema: If you have ever experienced angioedema (swelling of the face, lips, or tongue), whether it was caused by a previous ACE inhibitor or was idiopathic (unknown cause) or hereditary, you must not take Fosinopril. The risk of a recurrent, potentially fatal airway obstruction is too high.
2. 2Pregnancy: As detailed in the Black Box Warning, Fosinopril is contraindicated in the second and third trimesters of pregnancy due to the risk of severe fetal harm and death.
3. 3Coadministration with Aliskiren in Diabetes: Patients with diabetes mellitus must not take Fosinopril if they are also taking aliskiren, due to the extreme risk of renal impairment and hyperkalemia.
4. 4Hypersensitivity: If you have a known allergy to Fosinopril or any other ACE inhibitor (such as lisinopril, enalapril, or ramipril), you should not take this medication.

These are conditions where Fosinopril should be used with extreme caution and only if your doctor determines the benefit is necessary:

• Aortic Stenosis / Hypertrophic Cardiomyopathy: Patients with 'outflow obstruction' (narrowing of the heart valves or chambers) may be at risk of decreased coronary perfusion if their blood pressure drops too low.
• Renal Artery Stenosis: In patients with narrowing of the arteries supplying the kidneys, Fosinopril can cause a sudden and severe drop in kidney function.
• Severe Dehydration: Patients who are severely volume-depleted are at high risk for acute kidney failure and severe hypotension upon starting the drug.
• Autoimmune Diseases: Patients with collagen vascular diseases (like systemic lupus erythematosus) are at a higher risk of developing neutropenia (low white blood cell count).

There is a high degree of cross-sensitivity among ACE inhibitors. If you have had a severe reaction (like a rash or swelling) to one drug in this class, you are likely to have a similar reaction to Fosinopril. However, there is generally no cross-sensitivity between ACE inhibitors and other classes of blood pressure medications, such as Calcium Channel Blockers or Beta-Blockers.

> Important: Your healthcare provider will evaluate your complete medical history, including any previous drug reactions, before prescribing Fosinopril to ensure it is safe for you.

Fosinopril is classified as Pregnancy Category D. This means there is clear evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans.

• First Trimester: While data are less conclusive than for the later trimesters, some studies suggest a potential risk of cardiovascular and neurological malformations if taken during the first three months.
• Second and Third Trimesters: Use during this period is known to cause 'ACE inhibitor fetopathy.' This includes kidney failure in the fetus, low amniotic fluid (which leads to limb contractures and lung underdevelopment), and skull deformities.

If you are of childbearing age, you should use effective contraception while taking Fosinopril. If you become pregnant, stop the medication and contact your doctor immediately.

Fosinopril and its active metabolite, fosinoprilat, are excreted in human breast milk. Because of the potential for serious adverse reactions in nursing infants (including hypotension and kidney issues), a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother. Generally, for newborn or preterm infants, ACE inhibitors are avoided due to the risk of hypotension.

Fosinopril is approved for treating hypertension in children aged 6 years and older who weigh more than 50 kg. It has not been shown to be effective or safe in children younger than 6 or those with a very low glomerular filtration rate (GFR < 30 mL/min). There is no evidence that Fosinopril affects growth or development in older children, but long-term pediatric data are limited.

In clinical trials, no overall differences in effectiveness or safety were observed between patients over 65 and younger patients. However, older adults are more prone to 'orthostatic hypotension' (dizziness when standing up) and may have age-related declines in kidney function. Therefore, doctors often monitor elderly patients more frequently and may start with a 5 mg or 10 mg dose.

Because Fosinopril has a dual route of elimination (liver and kidney), it is often considered a safer ACE inhibitor for patients with mild to moderate kidney disease. As kidney function declines, the liver clears more of the drug. However, in cases of severe renal impairment (creatinine clearance < 10 mL/min), the clearance of fosinoprilat is reduced, and patients must be monitored very closely for toxicity and hyperkalemia.

In patients with hepatic impairment (such as cirrhosis), the conversion of Fosinopril to its active form may be slowed. However, the overall amount of active drug produced is not significantly changed. The kidneys will compensate for the reduced biliary excretion. No specific dose adjustment is usually required, but clinical monitoring is advised.

> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, nursing, or have any organ-specific health concerns.

Fosinopril is an ester prodrug of the active moiety fosinoprilat. Its primary molecular target is the Angiotensin-Converting Enzyme (ACE), a peptidyl dipeptidase. ACE is a zinc-containing enzyme that catalyzes the conversion of the decapeptide Angiotensin I to the octapeptide Angiotensin II. Angiotensin II is a potent vasoconstrictor and a stimulator of aldosterone secretion.

By competitively inhibiting ACE, Fosinoprilat reduces the concentration of Angiotensin II in the plasma and tissues. This leads to:

1. 1Vasodilation: Reduced contraction of vascular smooth muscle, leading to lower peripheral resistance.
2. 2Reduced Aldosterone: Lower levels of aldosterone lead to decreased sodium and water reabsorption in the distal tubule of the kidney.
3. 3Bradykinin Accumulation: ACE also degrades bradykinin (a vasodilator). Inhibition of ACE increases bradykinin levels, which stimulates the release of nitric oxide and prostacyclin, further aiding vasodilation.

The onset of the antihypertensive effect of a single 10-40 mg dose occurs within 1 hour, with peak reduction in blood pressure achieved between 2 and 6 hours. The effect lasts for 24 hours. With chronic dosing, the full blood-pressure-lowering effect may not be seen for several weeks. In heart failure, Fosinopril reduces pulmonary capillary wedge pressure (a measure of fluid in the lungs) and increases cardiac output.

| Parameter | Value |

|---|---|

| Bioavailability | 30% to 36% |

| Protein Binding | >95% (Fosinoprilat) |

| Half-life | ~12 hours (Effective accumulation half-life) |

| Tmax | ~3 hours (for Fosinoprilat) |

| Metabolism | Hydrolysis in liver/GI mucosa to Fosinoprilat |

| Excretion | Renal 50%, Biliary/Fecal 50% |

• Molecular Formula: C30H45NNaO7P
• Molecular Weight: 585.65 g/mol
• Solubility: Soluble in water and methanol.
• Structure: Fosinopril sodium is a white to off-white crystalline powder. It is chemically described as L-proline, 4-cyclohexyl-1-[[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]acetyl]-, sodium salt.

Fosinopril is a member of the ACE inhibitor class. It is categorized as a 'Type III' ACE inhibitor because it is a prodrug that contains a phosphinate group, distinguishing it from 'Type I' (like captopril, which has a sulfhydryl group) and 'Type II' (like enalapril or lisinopril, which have dicarboxylate groups).